Annual EBIT
-$16.81 M
+$6.28 M+27.21%
31 December 2023
Summary:
Akari Therapeutics annual earnings before interest & taxes is currently -$16.81 million, with the most recent change of +$6.28 million (+27.21%) on 31 December 2023. During the last 3 years, it has risen by +$1.18 million (+6.53%). AKTX annual EBIT is now -2021.97% below its all-time high of -$792.00 thousand, reached on 31 December 2010.AKTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$2.83 M
+$4.68 M+62.36%
01 September 2024
Summary:
Akari Therapeutics quarterly earnings before interest & taxes is currently -$2.83 million, with the most recent change of +$4.68 million (+62.36%) on 01 September 2024. Over the past year, it has increased by +$45.00 thousand (+1.57%). AKTX quarterly EBIT is now -143.70% below its all-time high of $6.47 million, reached on 31 December 2015.AKTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$27.26 M
+$45.00 K+0.16%
01 September 2024
Summary:
Akari Therapeutics TTM earnings before interest & taxes is currently -$27.26 million, with the most recent change of +$45.00 thousand (+0.16%) on 01 September 2024. Over the past year, it has dropped by -$15.79 million (-137.75%). AKTX TTM EBIT is now -1347.58% below its all-time high of -$1.88 million, reached on 31 March 2014.AKTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKTX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.2% | +1.6% | -137.8% |
| 3 y3 years | +6.5% | -93.1% | -49.5% |
| 5 y5 years | +28.4% | +9.3% | -86.0% |
AKTX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +27.2% | -93.1% | +74.2% | -217.2% | +0.2% |
| 5 y | 5 years | at high | +28.4% | -1044.6% | +74.2% | -217.2% | +0.2% |
| alltime | all time | -2022.0% | +60.2% | -143.7% | +93.8% | -1347.6% | +46.1% |
Akari Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.83 M(-62.4%) | -$27.26 M(-0.2%) |
| June 2024 | - | -$7.51 M(+25.3%) | -$27.30 M(+14.7%) |
| Mar 2024 | - | -$5.99 M(-45.2%) | -$23.80 M(+6.2%) |
| Dec 2023 | -$16.81 M(-27.2%) | -$10.94 M(+280.9%) | -$22.40 M(+95.4%) |
| Sept 2023 | - | -$2.87 M(-28.2%) | -$11.46 M(+33.4%) |
| June 2023 | - | -$4.00 M(-12.9%) | -$8.59 M(-17.4%) |
| Mar 2023 | - | -$4.59 M(-21.0%) | -$10.41 M(-43.4%) |
| Dec 2022 | -$23.09 M(+34.1%) | - | - |
| June 2022 | - | -$5.82 M(+10.9%) | -$18.40 M(+8.8%) |
| Mar 2022 | - | -$5.24 M(-10.7%) | -$16.91 M(-1.8%) |
| Dec 2021 | -$17.21 M(-4.3%) | -$5.87 M(+301.3%) | -$17.21 M(-5.6%) |
| Sept 2021 | - | -$1.46 M(-66.2%) | -$18.24 M(+7.1%) |
| June 2021 | - | -$4.33 M(-22.0%) | -$17.02 M(-8.5%) |
| Mar 2021 | - | -$5.55 M(-19.5%) | -$18.60 M(+3.5%) |
| Dec 2020 | -$17.98 M(+6.0%) | -$6.90 M(+2692.8%) | -$17.98 M(-4.9%) |
| Sept 2020 | - | -$246.90 K(-95.8%) | -$18.91 M(-13.2%) |
| June 2020 | - | -$5.91 M(+20.0%) | -$21.78 M(-0.5%) |
| Mar 2020 | - | -$4.93 M(-37.0%) | -$21.90 M(+29.1%) |
| Dec 2019 | -$16.96 M(-27.8%) | -$7.83 M(+151.1%) | -$16.96 M(+15.8%) |
| Sept 2019 | - | -$3.12 M(-48.3%) | -$14.65 M(-14.9%) |
| June 2019 | - | -$6.03 M(<-9900.0%) | -$17.22 M(-10.2%) |
| Mar 2019 | - | $12.00 K(-100.2%) | -$19.17 M(-18.4%) |
| Dec 2018 | -$23.49 M | -$5.52 M(-3.0%) | -$23.49 M(-18.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$5.69 M(-28.7%) | -$28.88 M(-9.0%) |
| June 2018 | - | -$7.98 M(+85.3%) | -$31.74 M(+2.0%) |
| Mar 2018 | - | -$4.31 M(-60.5%) | -$31.11 M(-11.3%) |
| Dec 2017 | -$35.08 M(+28.8%) | -$10.91 M(+27.7%) | -$35.08 M(+3.1%) |
| Sept 2017 | - | -$8.54 M(+16.2%) | -$34.03 M(+8.0%) |
| June 2017 | - | -$7.35 M(-11.3%) | -$31.51 M(-0.5%) |
| Mar 2017 | - | -$8.28 M(-15.9%) | -$31.68 M(+16.3%) |
| Dec 2016 | -$27.25 M(-35.5%) | -$9.85 M(+63.6%) | -$27.25 M(+149.3%) |
| Sept 2016 | - | -$6.02 M(-19.9%) | -$10.93 M(-78.4%) |
| June 2016 | - | -$7.52 M(+95.2%) | -$50.59 M(+13.9%) |
| Mar 2016 | - | -$3.85 M(-159.6%) | -$44.41 M(+5.1%) |
| Dec 2015 | -$42.26 M(+2076.2%) | $6.47 M(-114.2%) | -$42.25 M(-15.2%) |
| Sept 2015 | - | -$45.68 M(+3313.6%) | -$49.83 M(+1041.1%) |
| June 2015 | - | -$1.34 M(-20.9%) | -$4.37 M(-18.5%) |
| Mar 2015 | - | -$1.69 M(+51.6%) | -$5.36 M(-3.4%) |
| Dec 2014 | -$1.94 M(-43.2%) | -$1.12 M(+406.8%) | -$5.55 M(+25.2%) |
| Sept 2014 | - | -$220.20 K(-90.5%) | -$4.43 M(+5.2%) |
| June 2014 | - | -$2.33 M(+23.7%) | -$4.21 M(+123.7%) |
| Mar 2014 | - | -$1.88 M | -$1.88 M |
| Dec 2013 | -$3.42 M(+1.4%) | - | - |
| Dec 2012 | -$3.37 M(+50.0%) | - | - |
| Dec 2011 | -$2.25 M(+183.7%) | - | - |
| Dec 2010 | -$792.00 K | - | - |
FAQ
- What is Akari Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Akari Therapeutics?
- What is Akari Therapeutics annual EBIT year-on-year change?
- What is Akari Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Akari Therapeutics?
- What is Akari Therapeutics quarterly EBIT year-on-year change?
- What is Akari Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Akari Therapeutics?
- What is Akari Therapeutics TTM EBIT year-on-year change?
What is Akari Therapeutics annual earnings before interest & taxes?
The current annual EBIT of AKTX is -$16.81 M
What is the all time high annual EBIT for Akari Therapeutics?
Akari Therapeutics all-time high annual earnings before interest & taxes is -$792.00 K
What is Akari Therapeutics annual EBIT year-on-year change?
Over the past year, AKTX annual earnings before interest & taxes has changed by +$6.28 M (+27.21%)
What is Akari Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of AKTX is -$2.83 M
What is the all time high quarterly EBIT for Akari Therapeutics?
Akari Therapeutics all-time high quarterly earnings before interest & taxes is $6.47 M
What is Akari Therapeutics quarterly EBIT year-on-year change?
Over the past year, AKTX quarterly earnings before interest & taxes has changed by +$45.00 K (+1.57%)
What is Akari Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of AKTX is -$27.26 M
What is the all time high TTM EBIT for Akari Therapeutics?
Akari Therapeutics all-time high TTM earnings before interest & taxes is -$1.88 M
What is Akari Therapeutics TTM EBIT year-on-year change?
Over the past year, AKTX TTM earnings before interest & taxes has changed by -$15.79 M (-137.75%)